These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23907518)

  • 21. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of in-transit metastases from cutaneous malignant melanoma.
    Hayes AJ; Clark MA; Harries M; Thomas JM
    Br J Surg; 2004 Jun; 91(6):673-82. PubMed ID: 15164434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of melanoma in-transit metastases confined to the limb.
    Eggermont AM
    Cancer Surv; 1996; 26():335-49. PubMed ID: 8783582
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?
    Testori A; Intelisano A; Verrecchia F; Menicanti C; Tosti G; Grassi E; Pari C; Pennacchioli E
    Dermatol Ther; 2012; 25(5):443-51. PubMed ID: 23046023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study and treatment of locally advanced melanoma].
    Moreno-Ramírez D; de la Cruz L; Ferrándiz L; Camacho FM
    Actas Dermosifiliogr; 2009 Nov; 100(9):767-79. PubMed ID: 19889298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of local or regional non-nodal disease.
    Racz JM; Block MS; Baum CL; Jakub JW
    J Surg Oncol; 2019 Jan; 119(2):187-199. PubMed ID: 30548554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. History of regional chemotherapy for cancer of the extremities.
    Ariyan CE; Brady MS
    Int J Hyperthermia; 2008 May; 24(3):185-92. PubMed ID: 18392997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy.
    Eggermont AM; ten Hagen TL
    Curr Oncol Rep; 2003 Mar; 5(2):79-80. PubMed ID: 12583823
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacotherapy of regional melanoma therapy.
    Padsis J; Turley R; Tyler D
    Expert Opin Pharmacother; 2010 Jan; 11(1):79-93. PubMed ID: 20001431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthermic perfusion for melanoma of the extremities: experience with 165 patients, 1967 to 1979.
    Stehlin JS
    Ann N Y Acad Sci; 1980; 335():352-5. PubMed ID: 6931528
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.
    Han D; Beasley GM; Tyler DS; Zager JS
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1383-94. PubMed ID: 21978383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic perfusion of extremities for melanoma and soft tissue sarcomas.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF; Gutierrez AA
    Recent Results Cancer Res; 1977; (59):171-85. PubMed ID: 408886
    [No Abstract]   [Full Text] [Related]  

  • 36. [Assessment of regional and systemic toxicity of isolated hyperthermic extremity perfusion with tumor necrosis factor-alpha and melphalan].
    Hohenberger P; Haier J; Kettelhack C; Schulze G; Schlag PM
    Chirurg; 1997 Sep; 68(9):914-20. PubMed ID: 9410682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.
    Storm FK; Sparks FC; Morton DL
    Surg Gynecol Obstet; 1979 Jul; 149(1):17-21. PubMed ID: 451822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma: the management of local recurrence and in-transit metastasis.
    Couture J
    Can J Surg; 1982 Nov; 25(6):698-700. PubMed ID: 7139431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
    Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
    Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.